MD1003 (High-Dose Biotin) for the treatment of progressive multiple sclerosis: baseline data and results from a cohort of patients included in a early access program

被引:0
|
作者
Brassat, D. [1 ]
Hautecoeur, P. [2 ]
Durand-Dubief, F. [3 ]
Castelnovo, G. [4 ]
Derache, N. [5 ]
Bourre, B. [6 ]
Le Page, E. [7 ]
Donze, C. [8 ]
Audoin, B. [9 ]
Ouallet, J-C. [10 ]
Collongues, N. [11 ]
Simon, O. [12 ]
Brion, G. [12 ]
Vermersch, P. [13 ]
机构
[1] Hop Pierre Paul Riquet, Dept Neurol, Toulouse, France
[2] Catholic Inst Lille, Grp Hop, Lomme Les Lille, France
[3] Pierre Wertheimer Hosp, Dept Neurol, Rhone, France
[4] Caremeau Hosp, Dept Neurol, Nimes, France
[5] CHU Caen, Caen, France
[6] Rouen Normandy Univ, Rouen, France
[7] Univ Hosp Pontchaillou, Rennes, France
[8] Catholic Inst Lille, Grp Hop, Lille, France
[9] Hop la Timone, APHM, Serv Neurol, Marseille, France
[10] CHU Pellegrin, Bordeaux, France
[11] Univ Hosp Strasbourg, Dept Neurol, Strasbourg, France
[12] Medday Pharmaceut, Paris, France
[13] Univ Lille, Lille, France
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
EP1776
引用
收藏
页码:936 / 937
页数:2
相关论文
共 50 条
  • [41] Frequency and description of relapses in a cohort of progressive multiple sclerosis patients treated with high dose biotin
    Liegey, J. S.
    Brochet, B.
    Moroso, A.
    Ruet, A.
    Ouallet, J. C.
    Louiset, P.
    Guerard, P.
    Deloire, M.
    Dulau, C.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 917 - 918
  • [42] 24-Month-Treatment with-MD1003 (High Doses of Biotin) in Progressive Multiple Sclerosis: Results of the MS-SPI Trial Extension Phase
    Tourbah, Ayman
    Lebrun-Frenay, Christine
    Edan, Gilles
    Clane, Michel
    Papeix, Caroline
    Vukusic, Sandra
    De Seze, Jerome
    Debouverie, Marc
    Gout, Olivier
    Clavelou, Pierre
    Defer, Gilles
    Laplaud, David
    Moreau, Thibault
    Labauge, Pierre
    Brochet, Bruno
    Sedel, Frederic
    Pelletier, Jean
    [J]. NEUROLOGY, 2016, 86
  • [43] Remotely Monitored Ambulatory Activity Correlates With Disability In Progressive MS: Baseline Data From The SPI2 Ph3 Trial Of Md1003 (hdpb Biotin)
    Block, V. J.
    Alexander, A. M.
    Papinutto, N.
    Rajesh, A.
    Gundel, T.
    Gelfand, J. M.
    Henry, R.
    Sedel, F.
    Cree, B. A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 34 - 35
  • [44] Remotely Monitored Ambulatory Activity Correlates with Disability in Progressive MS: A Baseline Analysis from the SPI2 Phase 3 Clinical Trial of MD1003 (High Dose Pharmaceutical Grade Biotin)
    Block, Valerie J.
    Alexander, Amber
    Papinutto, Nico
    Rajesh, Anand
    Gundel, Tristan
    Gelfand, Jeffrey M.
    Henry, Roland G.
    Sedel, Frederic
    Cree, Bruce A. C.
    [J]. NEUROLOGY, 2020, 94 (15)
  • [45] High-dose biotin in progressive multiple sclerosis: A prospective study of 178 patients in routine clinical practice
    Couloume, Laura
    Barbin, Laetitia
    Leray, Emmanuelle
    Wiertlewski, Sandrine
    Le Page, Emmanuelle
    Kerbrat, Anne
    Ory, Solenn
    Le Port, Damien
    Edan, Gilles
    Laplaud, David-Axel
    Michel, Laure
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (14) : 1898 - 1906
  • [46] High-dose biotin in progressive multiple sclerosis: a prospective study of 178 patients in routine clinical practice
    Couloume, L.
    Barbin, L.
    Wiertlewski, S.
    Le Page, E.
    Kerbrat, A.
    Ory, S.
    Le Port, D.
    Edan, G.
    Laplaud, D. -A.
    Michel, L.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 529 - 530
  • [47] High-dose biotin in progressive multiple sclerosis : a prospective study of 86 patients in routine clinical practice
    Couloume, L.
    Ory, S.
    Wiertlewski, S.
    Laplaud, D. -A.
    Michel, L.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 969 - 969
  • [48] Spinal Cord Area Correlates with Disability and Quality of Life in Progressive MS: A Baseline MRI Analysis from the SPI2 Phase 3 Trial of MD1003 (high dose Pharmaceutical grade Biotin)
    Alexander, Amber M.
    Block, Valerie J.
    Papinutto, Nico
    Rajesh, Anand
    Gundel, Tristan
    Arnold, Douglas
    Sedel, Frederic
    Cree, Bruce A. C.
    Henry, Roland G.
    [J]. NEUROLOGY, 2020, 94 (15)
  • [49] Relapses During High-Dose Biotin Treatment in Progressive Multiple Sclerosis: a Case-Crossover and Propensity Score-Adjusted Prospective Cohort
    Pierre Branger
    Jean-Jacques Parienti
    Nathalie Derache
    Nizam Kassis
    Rana Assouad
    Elisabeth Maillart
    Gilles Defer
    [J]. Neurotherapeutics, 2020, 17 : 989 - 993
  • [50] Relapses During High-Dose Biotin Treatment in Progressive Multiple Sclerosis: a Case-Crossover and Propensity Score-Adjusted Prospective Cohort
    Branger, Pierre
    Parienti, Jean-Jacques
    Derache, Nathalie
    Kassis, Nizam
    Assouad, Rana
    Maillart, Elisabeth
    Defer, Gilles
    [J]. NEUROTHERAPEUTICS, 2020, 17 (03) : 989 - 993